Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following recent ...
Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.
Flare-ups can occur anywhere on the body but are most commonly found on the arms, legs, behind the knees, hands, and areas of the face, such as the eyelids and around the mouth. Eczema is believed to ...